Skip to the page

Data / Form D filings / Apothewell, Inc.

Apothewell, Inc.: Form D filings

Apothewell, Inc., a biotechnology company in Little Rock, AR, filed 5 Form D notices with the SEC between 2021 and 2023. The latest, on December 15, 2023, reports $11,000 sold of a $200,000 offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
417 MAIN STREET, Little Rock, AR, 72201
Phone
(501) 376-3800
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Arkansas
Year incorporated
2021
Revenue range
$1 - $1,000,000
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1876860

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Dec 15, 2023New notice$200,000$11,000$189,0001Dec 1, 2023sec.gov
Oct 13, 2023New notice$75,000$45,000$30,0009Sep 28, 2023sec.gov
Mar 28, 2023New notice$110,000$40,000$70,0001Mar 13, 2023sec.gov
Aug 11, 2022New noticeIndefinite$8,0001Aug 3, 2022sec.gov
Aug 4, 2021New noticeIndefinite$50,00010Jul 21, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Daniel SharpExecutive Officer, Director

Every Form D from the week of Dec 11, 2023 · All recent filings in Arkansas · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Apothewell, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.